Neutrophils play a key role in innate immune responses against foreign intrusion and influence the subsequent instigation of adaptive immune response. Nitric oxide (NO) synthesized by neutrophil nitric oxide synthase (NOS) profoundly modulates their diverse physiological responsibilities furthermore encompassing pathological implications. Neutrophils are the active participants in diverse inflammatory and cardiovascular disorders but neutrophil nitric oxide synthase (NOS) remains enigmatic on various aspects. This review focuses on inducible NOS (iNOS) and makes an attempt to address its potential impact in neutrophil pathophysiology, their differentiation, functionality, and survival. We described the scenario from its expressional modulation, by pro-and anti-inflammatory cytokines governing the extent and duration of neutrophil immune response, to iNOS catalysis, the intracellular compartmentalization, and protein-protein interactions determining its microenvironment, activity and its contribution as a potential signaling protein apart from its role as signal transducer. Further, the relevance of investigating the unexplored facets of iNOS biology in neutrophils and possible prototypes of iNOS regulation is also exemplified in related cellular systems.
INTRODUCTION
Since its discovery as endothelium-derived growth factor, NO has been related to a broad spectrum of signaling pathways in diverse pathophysiological, immunomodulatory, [1] [2] [3] and pharmacological responses.
NO regulates functional attributes of neutrophils modulating their chemotactic, phagocytic, migratory, and apoptotic activities 4 as elaborated in Fig. 1 . Neutrophils generate NO at a rate of (10-100) nmoles /5 min/10 6 cells. 5 These comprise 60-70% of the total peripheral leukocytes in humans, contribute significantly to the circulating levels, encompassing a widespread impact on cardiovascular homeostasis.
Being capable against invading pathogens, a tumor cell, and alloantigens, NO is an asset to these immunocompetent cells, adding more to their cytotoxic battalion. It has also been demonstrated that NO mediates neutrophil extracellular traps (NET) release at the site of Abbreviations: AL, arginosuccinate lyase; AS, arginosuccinate synthase; Asc, ascorbate; BH 4 , tetrahydrobioptein; CaM, calmodulim; CGD, chronic granulomatous disease; DHA, dehydroascorbate; ETC, electron transport chain; Hsp, heat shock protein; I B, inhibitor kappa B; NLS, nuclear localization signal; PDZ, PSD-95/Disc large/ZO-1; PKC, protein kinase C; RNI, reactive nitrogen intermediates; ROCK, Rho-associated coiled coil containing protein kinase; TGF, tumor growth factor inflammation / infection by augmenting free radical generation. 6 Study by Napimoga et al. 7 depicted that peroxisome proliferator-activated receptor-(PPAR-) reduces neutrophil migration to the acute inflammatory mesenteric lesion as a result of reduction of rolling and adhesion activities of neutrophils to endothelial cells, which required NO expression. The functional and molecular characterization of NOS isoforms has also been suggested in rat neutrophil precursor cells. 8 Neutrophil is terminally differentiated, spontaneously aging, and transcriptionally not so active cell but it might induce the expression of NOS at call by external modulators. The presence of both nNOS and iNOS has been accepted unequivocally by our group and others, 9, 10 while the occurrence of eNOS 11 is also being advocated and warranting further investigations. Previously, we have shown the NO mediated modulation of neutrophil response under diverse pathophysiological conditions like Parkinson's disease, 12 schizophrenia, 13 depression, 14 thrombosis, 15 and hypertension. 16, 17 The prime concern of these studies was to decipher the regulation of oxidative burst potential, offered by NO [17] [18] [19] [20] [21] and its oxidized metabolites by initiating a series of signaling cascade, involving nitrosylation and nitration events to trigger NADPH oxidase. Recently novel mechanisms through which NO regulates the activation of human T cells, and
consider their potential in strategies to treat tumoral, allergic, and autoimmune diseases has been discussed. 22 Since NOS has emerged as active player in numbers of physiological and pathological functions, it is the need to further review its specific mechanistic roles and implement them in development of new diagnosis or therapeutics.
This review provides an insight into the genetic, catalytic modulation, intracellular compartmentalization of iNOS, and its association with interacting proteins with emphasis to its relevance in the functioning of neutrophils. Investigations in neutrophils being inadequate, we have also included evidences from related cellular systems to provide the potential archetype of iNOS regulation that might be operational in these granulocytes, and may highlight the missing links, which are needed to be explored.
ROLE OF NEUTROPHIL iNOS IN PATHOLOGICAL CONDITIONS
Neutrophils pose a challenge of being both a friend and foe as activated neutrophils are the chief producers of free radicals, which in concert with proteolytic enzymes are detrimental in silencing the invading pathogens. But during prolonged inflammation these toxicants become deleterious in inflicting injury to the host. NO availability offers bimodal regulation of neutrophil immune response involving intricate signaling cascades. 4, 23 Moreover, unassumingly large storage of ascorbic acid in neutrophils supports NO synthesis 19, 20 apart from counteracting oxidative stress.
The potential importance of neutrophil is exemplified in several pathologies. Unwarranted production of NO turns deleterious in diseases like arthritis, glomerulonephritis, diabetes, stroke, septic shock, whooping cough, sepsis, encephalitis, and ulcerative colitis, which involve the active participation of neutrophils. [24] [25] [26] [27] [28] [29] [30] While in autoimmune disorders, immune rejection of allografted organs, graft vs. host disease, sepsis, encephalitis, and in ulcerative colitis neutrophils serve as active accomplice along with other immune cells. 24, 26, 30 The neutrophil outnumbers other leukocytes by a wide margin; hence a differential alteration at their level could bear far-fetched effects. NO both in an autocrine and paracrine manner revise interaction of neutrophils with other vascular components in preventing platelet aggregation in near vicinity, leukocyte adhesion to the post capillary venules, an increase in neutrophil derived NO following thrombosis 16 possibly restore blood flow and avoid ischemic consequences. Overexpression of iNOS in neutrophils might be accountable for the defective leukocyte-endothelial interaction in diabetes mellitus due to an increase in the expression of P-selectin and ICAM. 31 NO positively influences formation of cytonemes (membrane tubulovesicular extensions), as seen in presence of NO donor, which execute long range adhesion and contact particles for phagocytosis in 1, 2 intergrin independent but L-selectin dependent manner. 32 In embryonic cells, cytonemes serve as cellular probing organelles, anchoring appendages, and intercellular connectives, executing cytoplasm transport between adjacent cells. Endogenous NO mediated modulation of cytoneme formation during neutrophilic differentiation could be postulated to regulate the extent and rate of neutrophil turnover under pathophysiological conditions like neutropenia. In this regard, Fayed et al. 33 reported that increased NO production by platelets may contribute to bleeding tendency observed in uremia, a condition involving high urea levels, which may contribute to the regulation of inducible NO production in leukocytes. Increased iNOS activity in peripheral neutrophils from patients with congestive heart failure 34 has also been reported, which positively correlated with augmented levels of IL-6, atrial natriuretic peptide, and norepinephrine in circulation contribute to disease severity. Therefore, revising the modulatory effect of neutrophil NOS on the cardiovascular physiology becomes critical to ascertain the complications attributed by these granulocytes.
Neutrophils endowed with the cytotoxic properties that contribute to oxidative and inflammatory response in various pathologies is discussed in the following section. Participation of neutrophils and NO in ischemia reperfusion injury has also been well documented. 25, 27, 28 iNOS down-regulation augments adhesion and infiltration of neutrophils to the ischemic liver lobes during reperfusion. NO also modulates chemotactic migration of neutrophils to inflammatory foci. Secco et al. 35 reported enhanced migration and better survival of migrated neutrophils following administration of iNOS inhibitors.
Furthermore, Shanley et al. 36 observed a decline in the inflammatory response in the iNOS-/-mice accompanied by decreased neutrophil infiltration, enhanced IL-12 production, and inability to up-regulate the anti-inflammatory IL-10 causing sustained inflammation. Even septicemia patients also show elevated nitrite levels in peripheral circulation with normal or increased neutrophil count than those with neutropenia. 37 Therefore, NO mediated regulation on the migration of activated neutrophil during inflammation could be blissful in preventing target organ damage and failure as seen during multiple organ dysfunction syndromes and multiple organ failure. Dysfunction of neutrophil chemotaxis is also noted in localized aggressive periodontitis (LAP) showing enhancement in NOS activity. 38 Moreover, cytotoxicity of neutrophil derived NO also presumably influences the onset of endotoxin shock. 37, 39 These explorations could help in setting clinical objectives to exert a control over neutrophil iNOS and their pro-inflammatory properties to accomplish better remedy.
An increase in reactive nitrogen intermediates (RNI) and infiltration of activated neutrophils in synovial fluid have been reported in rheumatoid arthritis. 40 The pathophysiology attributed by neutrophils is deliberate oxidative injury caused at the inflammatory site; though a study has demonstrated that up-regulation of neutrophil-iNOS and presence of gp91 phox are not essential requisites for the onset of this pathological condition, however contribute to its progression and severity. 41 Enhancement in neutrophil NOS expression or activity is not always deleterious though. Targeted infiltration of activated neutrophils to tumor sites with an upregulated iNOS activity emphasizes the combinatorial effect of NO in tumor pathology. 42 Tsuji et al. 43 reported the enhanced NO generation in neutrophils from chronic granulomatous disease patients, which might be compensatory mechanism for impaired oxidative burst.
EXPRESSIONAL REGULATION OF NEUTROPHIL iNOS

Alternative splicing: On/off switch
The iNOS gene itself offers transcriptional control at an organization level having four alternative mRNA transcripts of human iNOS with tissue specific preponderance-alveolar macrophages (exon 5-), bronchial epithelial cells (exons 5-,8-,9-and exons 9-,10-,11-), lung tissues (exons 15-and 16-), and brain tissues (exon 5-) presumably offering differential regulation across developmental lineages. 44 Although the resultant deletion in the amino acid sequence did not correspond to any of the known functional domains (except exon 5-, delivering a truncated protein), the protein product is unlikely to be functional. Alternate splicing modifies mRNA stability, enzyme catalysis, posttranslational modifications, and confers novel functions to the resultant iNOS variants. 44 Previous studies from our lab have demonstrated the presence of nNOS-[with PDZ domain] in rat neutrophils. 9 Further exploration of the splice variants of iNOS in pathophysiological situations where differential NO generation is monitored are however required.
Inflammatory mediators governing immune functions
The purpose of this discussion is to ascertain the potential regulatory elements that might be deliberately controlling iNOS expression in neutrophils as evidenced in other myeloid cells and other phagocytes.
Optimal promoter activation occurs with synergistic stimulations from various proinflammatory cytokines though the effective combinations vary between species and cell lineage depending on their inflammatory-factors dependent response profile.
Cytokine(s): Commanding neutrophil actions
Following invasion of neutrophils to the inflammatory loci the battery of cytokines from the provocative surroundings comes into play ( 
Chemokines to lead the neutrophil participation in pathological conditions
At the onset of inflammation chemokines like IL-8, bacterial peptides and LPS exert their impact on chemotaxis and transmigration of neutrophils to the targeted site; followed by the action of cytokines modulating neutrophil response and survival thus directing the course and duration of inflammation. Extravagated rat neutrophils exhibit timedependent augmentation in expression of iNOS, as compared to the circulating neutrophils, although not in humans suggesting different regulatory mechanisms across species. 55 Sub-lethal dose (0.5 mg/kg, i.v.) of LPS augments production of RNI through iNOS induction mediated by TNF- 56 or else elevates intracellular calcium and activates PKC to increase iNOS expression. 57 Prednisolone suppresses this LPS induction by interfering with iNOS transcription, whereas 3-amino, 1, 2, 4-triazine inhibits nitrite and nitrate production presumably posing an inhibition on catalysis. 56, 58 dbcAMP and purine 2 receptor agonist methyl thio-ATP effectively increase iNOS mRNA transcription in alveolar macrophages comparable to or even greater than that induced by intra-tracheal administration of LPS, 58 independent of neutrophil infiltration elevation of TNF-, and involvement of NF-B. But again LPS is more prompt in up-regulating arginine transport and the level of tetrahydrobiopterin (BH 4 ) offering two pronged effects. Nevertheless existence of a direct alternate pathway for iNOS induction independent of cytokines is of clinical significance in patients with asthma and restrictive lung diseases as localized iNOS induction might offer long lasting bronchodilation without affecting the systemic circulation.
Contribution of cytoskeletal network
Neutrophils undergo excessive cytoskeletal reorganization during activation and phagocytosis, which needs to be correlated with expression and trafficking of NOS since both the functions are modulated by certain level of NO. Endogenous NO from iNOS makes neutrophils deformable in an autocrine manner as observed in LPS treated rats. 59 Deformability signals are inevitably relayed through alteration in the cytoskeletal framework making it essential to decipher the potential targets of NO in cytoskeletal framework of neutrophils.
Disruption of the intermediate filaments in cytoskeletal network is a pre-requisite for aggresome formation to sequester iNOS until proteolytic degradation. 60 Thus, the cytoskeletal network evokes trafficking of NOS to sites of action in the phagosomes or organelles for localizing NOS activity as per need; while NO critically inspects the changes in the cytoskeletal parameters ensuring a mutual effect on each other.
Furthermore, Rho GTPase (Rho, Rac, and Cdc 42) signaling mediated through ROCK suppresses the iNOS expression in human epithelial cells. 61 Several studies have shown that Rac1 plays an important role in the regulation of eNOS activity in endothelial cells. A study using tissue-specific knockin mice with a 50% reduction of Rac1 in the endothelium has revealed that this GTPase regulates eNOS function at several levels, including the up-regulation of gene transcription, transcript stability, and its catalytic activity. 62 It has also been explored that Rac1 is involved in the NO-regulated Vav2 pathway, unveiling a new signal transduction pathway that ensures proper NO-dependent responses in mouse vascular smooth muscle cells. 63 Since independent reports have shown that NO and Vav proteins play important roles in T lymphocytes, 64, 65 it will be interesting to investigate whether these proteins could also work in a concerted manner in neutrophils too or not. 
The negative negotiators
REGULATION OF THE CATALYTIC MACHINERY
The regulatory mechanisms governing NOS activity are as different as the isoforms themselves and possibly account for differential participation of these isoforms in assorted physiological activities. Among the isoforms, iNOS is supposed to be the dominant executor mediating inflammatory functions. Stuehr et al. 73 
Status of raw material for synthesis
Catalysis of NO is initiated only once substrate is available in near vicinity in optimal concentrations. Mechanism based pharmacological inhibitors reveal its catalytic mechanism. 74 Arginine can be obtained from exogenous sources, intracellular protein degradation, or endogenous synthesis (urea cycle) and released into the circulation. The intracellular substrate reservoir in human neutrophils is 5.22 ± 0.46 nmol/10 8 cells. 75 L-Arginine, a conditionally essential amino acid is essential during growth and becomes limiting during several pathological conditions and likely to affect NO generation. 75 Under such conditions NOS is likely to perform functions other than catalytic or else contribute to the generate superoxide instead of NO.
Transport from exogenous source
Arginine transport is a rate-limiting phenomenon and mediated through cationic amino acid transporters. 76 78 Induction of iNOS is concomitantly associated with the induction of cat-2 gene encoding high affinity L-arginine transporter system in rat cultured astrocytes to cope with increased demand of substrate. 79 
The arginine paradox
"Arginine paradox" refers to dependence of cellular NO production on exogenous L-arginine concentration despite theoretical saturation with intracellular L-arginine. It might serve as a potential mechanism to check constitutive iNOS activity in neutrophils. L-arginine blocks NO production in cytokine-stimulated astrocytes by inhibiting translation of iNOS mRNA, without affecting promoter activity and stability. 80 This provides a basis of arginine paradox for regulating iNOS and defines a distinct mechanism by which a substrate can regulate the associated enzyme activity.
Recycling from citrulline through urea cycle also contributes to the 
Cofactors-not mere supporting pillars
BH 4 levels
Of all the co-factors involved in catalysis, we emphasize BH 4 since stability of this extremely reduced molecule in the oxidative environment of neutrophils, is quite a challenge in itself to sustain NOS catalysis.
The reduced BH 4 is essential as oxidized BH 4 abolishes the stimulation offered by reduced derivatives. [81] [82] [83] Ascorbic acid depot in neutrophils might be stabilizing BH 4 in neutrophils like in endothelial cells and thereby boosting NOS activity apart from keeping the redox balance. During inflammatory conditions when iNOS is induced the BH 4 availability in neutrophils, it might be limiting due to the enhancement of oxidative burst unless synthesis of BH 4 triggered simultaneously. Given such situations NOS could add more to the superoxide load generated during respiratory burst. Decreased BH 4 bioavailability contributes to pathological conditions such as hyperhomocysteinemia, a risk factor for cardiovascular diseases that induces endothelial dysfunction. 83 These situations also offer opportunities to postulate potential non-catalytic roles of NOS in neutrophils. 
Sequestering the signal transducer
SEQUESTRATION OF iNOS
Sequestration of iNOS to intracellular compartments as depicted in Table 2 is brought about by scaffolding and docking proteins, which govern its activity, redistribution, and proximity with regulators and intended targets. iNOS interacts with inhibitory elements kalirin 86 and NOS-associated protein, 87 as well as activator proteins, the Rac GTPases. 88 Previous study has demonstrated that pathological events are associated with the increase, inhibition, or mislocalization of nitric oxide production. 89 Protein-protein interactions also modulate iNOS induction by cytokines. 84, 90, 91 On the other hand the calpain and ubiquitin-proteosome pathways are the major proteolytic mechanisms responsible for the regulated degradation of NOS isozymes. 92 Distribution of iNOS and nNOS in various intracellular compartments along with their prominent presence in nucleus was evidenced in rat neutrophils. 9 Here, we discuss some of the unexplored area in context of neutrophils, while scrutinizing relevant experimentations in related cellular system, which are critical and should be considered for the possibilities and usefulness of such interactions in influencing neutrophil functionality.
TA B L E 1 Protein-protein interactions involving inducible nitric oxide synthase
NOS interacting proteins
Domains of interacting protein NOS sequence involved in interaction
Tissue/cell line 
TA B L E 2 Subcellular distribution of iNOS in different cells/tissues
Subcellular organelles Type of cells/tissues References
Primary granules Human neutrophils and eosinophils, rat neutrophils and eosinophils Bone marrow neutrophil precursor cells 8, 9, 113, 120 Phagosomes RAW 264, mice and human neutrophils 105, 121 Mitochondria Rat cardiomyocytes, neutrophils 9, 122 Golgi Rat ventricular myocytes, RAW 264, HT29, DLD1 
iNOS trafficking to the caveolar compartments
Neutrophils are phagocytic cells extensively involved in intracellular and extracellular vesicular transport to serve their immune purpose.
Protein constituents of vesicular transport, such as caveolin and dynamin, might be involved in iNOS trafficking to and out of compartments. Neutrophils were previously shown to be devoid of caveolin in the plasmalemmal caveolae. 93 However, later we have showed the association of caveolin-1 and iNOS by confocal and electron microscopic explorations, 9 which might be accounting for its reduced/lack of activity as reported earlier. 94 Caveolin, imposes an inhibitory effect on iNOS, 92, 95 antagonized by NOSIP (modulator of eNOS), 96 Ca 2+ /CaM, and phosphorylation events suggesting a 'caveolin cycle' of activation/inactivation and relocation of the enzyme. 97 
Hsp90: Modulation offered by the molecular chaperon
Rac isofoms: Spatial redistribution within cell
The Rho/Rac GTPase, subclassified as Rho, Rac, and Cdc42, upon activation, bind to effectors, which are responsible for triggering disparate biological responses, such as F-actin cytoskeletal changes, cell polarity, 
MITOCHONDRIAL iNOS: MODULATING THE MODE OF METABOLISM OR SURVIVAL?
Mitochondrial involvement in neutrophil physiology has gained impor- 
NUCLEAR iNOS: GOOD, BAD, OR UGLY?
Neutrophils sequester iNOS to phagosomes, azurophilic granules, plasma membrane, and even in nucleus 9 where a correlation with its functionality needs to be deciphered. Interestingly nuclear localization of BH 4 biosynthetic enzymes GTP cyclohydrolase-I, 6-pyruvoyltetrahydropterin synthase and sepiapterin reductase provides connotation in this context 108 to guarantee BH 4 availability at call.
Functional iNOS and eNOS in brown adipocyte nucleus have been related to raise the rate of lipid metabolism and inhibit the oxidative phosphorylation. 109 Similarly nuclear iNOS in neutrophils could speculatively be one of the governing factors determining the mode of metabolism and energy status, involved in regulation of genes during terminal differentiation or those governing inflammatory responses.
It might also deliver genotoxic RNI thus speeding up senescence. 110 Nuclear nNOS acts in protein trafficking, such as employing its PDZ domain for nucleo-cytoplasmic shuttling of carboxy terminal binding protein (CtBP). 111 Similarly growth factor-independent (HMC-1) and dependent (LAD2) MC cell lines exhibit predominant nuclear eNOS colocalization with the leukotriene-initiating enzyme 5-lipoxygenase (5-LO), where NO seems to be interfering with its release. 112 Treatment with Ca2+ ionophore A23187 or IgE-anti-IgE in these cells, cause NOS phosphorylation and translocation to the nucleus 112 providing a glimpse of the intracellular signaling cascade involved in this process. Nuclear iNOS has also been reported in eosinophils where its function is still need to be determined. 113 Caveolin bearing nuclear localization signal (NLS) sequence attracts attention as a potential candidate to mediate trafficking of iNOS to nucleus in a nonfunctional but ready to be activated state without influencing other ongoing intracellular events. We have indeed evidenced colocalization of caveolin and iNOS in the nucleus but also found iNOS in a functionally active state. 9 Hence, what remain to be explored are the intricate events causing dissociation of caveolin from iNOS to render it functionally. Nuclear iNOS might be involved in disrupting and extricating the genetic material to form extracellular traps for extracellular bacterial killing. 114 
CONCLUSION
NO being pleotropic is employed in mediating assorted cellular programs, which raises inquisitiveness regarding the intrinsic synthetic machinery of this signal transducer. Updates related to this field are still accruing with new discoveries adding more to the complexity of this enzyme. NO modulates diverse physiological functions in neutrophils and also has pathological implications, which has been widely and extensively documented providing a clarified understanding, but NOS as an enzyme and signaling protein in the context of neutrophils warrants proper investigation. Contemplating on available literature, the present review primarily addresses the need for focused research to fill in the gaps of the fretsaw puzzle. We therefore attempted to highlight the unexplored facets of NOS biology in neutrophil by comparing with studies in developmentally or functionally related cells, and speculated the importance of such explorations in revealing the functional significance of NOS in neutrophils under diverse pathophysiological situations.
